Replication of the VERO Osteoporosis Trial in Healthcare Claims Data
Condition:   Osteoporosis Interventions:   Drug: Teriparatide;   Drug: Risedronate Sponsor:   Brigham and Women's Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2021 Category: Research Source Type: clinical trials

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
Conditions:   Secondary Hyperparathyroidism;   Chronic Kidney Disease-Mineral and Bone Disorder;   Dialysis;   Hypocalcemia;   Hypoparathyroidism Intervention:   Drug: Teriparatide Sponsor:   Saint Petersburg State University, Russia Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2021 Category: Research Source Type: clinical trials